High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease
- PMID: 8496677
- PMCID: PMC2191033
- DOI: 10.1084/jem.177.6.1567
High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease
Abstract
The frequencies of human T cell lymphotropic virus type 1 (HTLV-1)-specific CD8+ precursor cytotoxic T lymphocytes (pCTL) were quantitated from lymphocytes obtained from the peripheral blood and cerebrospinal fluid (CSF) of infected individuals with and without HTLV-1-associated neurological disease. An estimate of the pCTL was obtained by separating CD8+ cells, plating these cells in limiting dilution, and testing wells for HTLV-1 specific lysis. Targets consisted of autologous lymphoblastoid cell lines (LCL) infected with vaccinia constructs expressing HTLV-1 gene products or LCL pulsed with HTLV-1 synthetic peptides. In patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), the frequency of HTLV-1 p40X-specific pCTL was at least 40-280-fold higher than in asymptomatic HTLV-1-infected individuals. All HAM/TSP patients (five of five) predominantly recognized HTLV-1 products encoded within the pX region. Lower pCTL to env were demonstrated in three patients, and only one of five HAM/TSP patients had pCTL to gag. A synthetic peptide corresponding to the tax region of HTLV-1 (peptide 11-19, amino acid sequence LLFGYPVYV) was recognized in association with human histocompatibility leukocyte antigen (HLA)-A2 in two HLA-A2 HAM/TSP patients with a high CD8+ pCTL frequency of 1/325 and 1/265, respectively. A second immunodominant region of HTLV-1 tax (peptide 90-55, amino acid sequence VPYKRIEEL) was identified to be restricted by HLA-B14 in two HLA-B14 HAM/TSP patients with a CD8+ pCTL frequency of 1/640 and 1/1,125, respectively. Lymphocytes from the CSF of a patient with HAM/TSP also showed a pCTL frequency against p40X of similar magnitude to that demonstrated from peripheral blood lymphocytes (PBL). The HLA-A2-mediated CSF pCTL activity to the immunodominant tax-specific peptide 11-19 was also comparable to pCTL from PBL. These results indicate that an extremely high pCTL frequency to HTLV-1 tax-encoded peptides may be related to pathogenesis of myeloneuropathy associated with HTLV-1.
Similar articles
-
Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.J Immunol. 1998 Jul 1;161(1):482-8. J Immunol. 1998. PMID: 9647259
-
Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.J Neuroimmunol. 1995 Dec;63(1):47-53. doi: 10.1016/0165-5728(95)00129-8. J Neuroimmunol. 1995. PMID: 8557824
-
Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.J Virol. 1996 Feb;70(2):843-51. doi: 10.1128/JVI.70.2.843-851.1996. J Virol. 1996. PMID: 8551623 Free PMC article.
-
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.Inflamm Allergy Drug Targets. 2008 Jun;7(2):98-107. doi: 10.2174/187152808785107642. Inflamm Allergy Drug Targets. 2008. PMID: 18691139 Review.
-
Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection.J Neurovirol. 1996 Oct;2(5):299-306. doi: 10.3109/13550289609146894. J Neurovirol. 1996. PMID: 8912206 Review.
Cited by
-
Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL responses.PLoS Pathog. 2023 Feb 2;19(2):e1011104. doi: 10.1371/journal.ppat.1011104. eCollection 2023 Feb. PLoS Pathog. 2023. PMID: 36730466 Free PMC article.
-
AIM™ platform: A new immunotherapy approach for viral diseases.Front Med (Lausanne). 2022 Dec 23;9:1070529. doi: 10.3389/fmed.2022.1070529. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36619639 Free PMC article.
-
The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine.Front Microbiol. 2022 May 4;13:897346. doi: 10.3389/fmicb.2022.897346. eCollection 2022. Front Microbiol. 2022. PMID: 35602078 Free PMC article. Review.
-
Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread.Retrovirology. 2021 Feb 23;18(1):6. doi: 10.1186/s12977-021-00550-8. Retrovirology. 2021. PMID: 33622348 Free PMC article.
-
Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.Front Microbiol. 2020 Dec 22;11:614940. doi: 10.3389/fmicb.2020.614940. eCollection 2020. Front Microbiol. 2020. PMID: 33414779 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
